NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
411 Lund |
Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
Benign sample | 1499 | 5.2% | 79 | 0.3% | 7 | 0.0% | 4 | 0.0% | 6 | 0.0% | 29 | 0.1% | 27007 | 94.3% | 28631 | 100.0% |
ASCUS | 1532 | 32.6% | 569 | 12.1% | 156 | 3.3% | 4 | 0.1% | 1 | 0.0% | 95 | 2.0% | 2348 | 49.9% | 4705 | 100.0% |
LSIL | 889 | 25.7% | 913 | 26.4% | 288 | 8.3% | 5 | 0.1% | 1 | 0.0% | 99 | 2.9% | 1266 | 36.6% | 3461 | 100.0% |
Atypical glandular cells/AGC | 63 | 41.2% | 11 | 7.2% | 2 | 1.3% | 14 | 9.2% | 2 | 1.3% | 6 | 3.9% | 55 | 35.9% | 153 | 100.0% |
Unclear atypia | 17 | 43.6% | 3 | 7.7% | 1 | 2.6% | 1 | 2.6% | . | . | 2 | 5.1% | 15 | 38.5% | 39 | 100.0% |
ASC-H | 92 | 17.0% | 123 | 22.7% | 281 | 51.8% | 7 | 1.3% | 5 | 0.9% | 7 | 1.3% | 27 | 5.0% | 542 | 100.0% |
HSIL | 44 | 7.1% | 45 | 7.3% | 462 | 74.5% | 19 | 3.1% | 16 | 2.6% | 12 | 1.9% | 22 | 3.5% | 620 | 100.0% |
Suspected Adenocarcinom | 5 | 9.8% | 1 | 2.0% | . | . | 24 | 47.1% | 11 | 21.6% | 2 | 3.9% | 8 | 15.7% | 51 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | . | . | . | . | . | . | 2 | 100.0% | 2 | 100.0% |
Malignant tumor with unclear origin | . | . | . | . | 2 | 25.0% | . | . | 5 | 62.5% | 1 | 12.5% | . | . | 8 | 100.0% |
Squamous cell cancer | . | . | 1 | 5.3% | 4 | 21.1% | . | . | 12 | 63.2% | . | . | 2 | 10.5% | 19 | 100.0% |
Totalt | 4141 | 10.8% | 1745 | 4.6% | 1203 | 3.1% | 78 | 0.2% | 59 | 0.2% | 253 | 0.7% | 30752 | 80.4% | 38231 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M69760, M80001, M80009, M80703, M80706, M81403, M81409, M83803, M83806, M84613, M89313 |